Acute Upper Respiratory Infection Clinical Trial
Official title:
The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)
Randomized, double blind, double dummy, positive drug parallel comparison, multi-centre clinical trial to assess the efficacy and safety of Fuganlin Oral Liquid in children with influenza (acute upper respiratory infection).
Treatment group: Fuganlin Oral Liquid 10mL. Control group: Xiaoer Jiebiao oral liquid 100mL. Treatment for one week. Patients who were recovered within one week can withdrawal at any time. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01694329 -
Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada
|
N/A | |
| Completed |
NCT04651491 -
Treatment of Influenza and ARVI in Children by Kagocel ®
|
||
| Completed |
NCT06457269 -
Evaluating the Potential of Large Language Models for Respiratory Disease Consultations
|
N/A | |
| Recruiting |
NCT04252963 -
Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
|
Phase 4 | |
| Withdrawn |
NCT01814293 -
Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs)
|
N/A | |
| Completed |
NCT01779271 -
Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
|
Phase 3 | |
| Recruiting |
NCT02539277 -
A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection
|
Phase 4 | |
| Completed |
NCT02983019 -
Treatment of Influenza in Routine Clinical Practice
|
N/A | |
| Completed |
NCT02654158 -
Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
|
N/A |